Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guoli Lin

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
International Journal of Medical Sciences|March 9, 2013
Efficacy of entecavir treatment for up to 5 years in nucleos(t)ide-naïve chronic hepatitis B patients in real lifeJie Luo, Xiangyong Li, Yuankai Wu, et al.
Experimental and Therapeutic Medicine|January 26, 2019
Efficacy of tenofovir disoproxil fumarate switch therapy in chronic hepatitis B patients with suboptimal response to adefovir-based combination therapyXiangyong Li, Jie Luo, Changhao Zhu, et al.
Journal of Clinical and Translational Hepatology|July 6, 2023
Double Plasma Molecular Adsorption System with Sequential Low-dose Plasma Exchange in Patients with Hepatitis B Virus-related Acute-on-chronic Liver Failure: A Prospective StudyLu Wang, Wenxiong Xu, Shu Zhu, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|September 1, 2014
[Efficacy of 48-week tenofovir disoproxil fumarate therapy in patients who were unresponsive to nucleoside-analogue treatments]Mingxing Huang, Xinhua Li, Yuankai Wu, et al.
Clinics and Research in Hepatology and Gastroenterology|November 25, 2015
Comprehensive analysis of hospital-based prospective cohort reveals the unique effectiveness and safety for nucleos(t)ide analogues in HBV patientsYuankai Wu, Yusheng Jie, Xiangyong Li, et al.
Plos One|October 29, 2015
24 versus 48 Weeks of Peginterferon Plus Ribavirin in Hepatitis C Virus Genotype 6 Chronically Infected Patients with a Rapid Virological Response: A Non-Inferiority Randomized Controlled TrialQingxian Cai, Xiaohong Zhang, Chaoshuang Lin, et al.
The Lancet. Oncology|June 20, 2015
A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control studyXue-Jia Lin, Yutian Chong, Zhi-Wei Guo, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
International Journal of Medical Sciences|March 9, 2013
Efficacy of entecavir treatment for up to 5 years in nucleos(t)ide-naïve chronic hepatitis B patients in real lifeJie Luo, Xiangyong Li, Yuankai Wu, et al.
Experimental and Therapeutic Medicine|January 26, 2019
Efficacy of tenofovir disoproxil fumarate switch therapy in chronic hepatitis B patients with suboptimal response to adefovir-based combination therapyXiangyong Li, Jie Luo, Changhao Zhu, et al.
Journal of Clinical and Translational Hepatology|July 6, 2023
Double Plasma Molecular Adsorption System with Sequential Low-dose Plasma Exchange in Patients with Hepatitis B Virus-related Acute-on-chronic Liver Failure: A Prospective StudyLu Wang, Wenxiong Xu, Shu Zhu, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|September 1, 2014
[Efficacy of 48-week tenofovir disoproxil fumarate therapy in patients who were unresponsive to nucleoside-analogue treatments]Mingxing Huang, Xinhua Li, Yuankai Wu, et al.
Clinics and Research in Hepatology and Gastroenterology|November 25, 2015
Comprehensive analysis of hospital-based prospective cohort reveals the unique effectiveness and safety for nucleos(t)ide analogues in HBV patientsYuankai Wu, Yusheng Jie, Xiangyong Li, et al.
Plos One|October 29, 2015
24 versus 48 Weeks of Peginterferon Plus Ribavirin in Hepatitis C Virus Genotype 6 Chronically Infected Patients with a Rapid Virological Response: A Non-Inferiority Randomized Controlled TrialQingxian Cai, Xiaohong Zhang, Chaoshuang Lin, et al.
The Lancet. Oncology|June 20, 2015
A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control studyXue-Jia Lin, Yutian Chong, Zhi-Wei Guo, et al.
Pageof 3